Status:
TERMINATED
Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Fetal Macrosomia
Obesity Complicating Childbirth
Eligibility:
All Genders
Brief Summary
This is a prospective, observational study which examines the association between maternal triglycerides in the antepartum period and fetal overgrowth in pregnancies complicated by gestational diabete...
Detailed Description
Gestational diabetes (GDM) is a condition of impaired insulin resistance which causes increased morbidity for mothers and newborns due to fetal overgrowth. Traditionally, GDM is diagnosed with a gluco...
Eligibility Criteria
Inclusion
- singleton pregnancy
- diagnosis of GDM between 24-32 weeks
- BMI \>= 30
Exclusion
- Conditions known to impact fetal growth.These conditions can develop after study enrollment but cannot be present at enrollment.
- autoimmune conditions treated with medication
- chronic hypertension requiring medication
- preeclampsia
- fetal growth restriction diagnosis
- smoking
- illicit drug use
- major fetal anomalies
- fetal genetic conditions
Key Trial Info
Start Date :
August 10 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT06067685
Start Date
August 10 2023
End Date
September 1 2024
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160